2,425
Views
37
CrossRef citations to date
0
Altmetric
Articles

Pharmacokinetics and in vitro and in vivo delivery of sulforaphane by PCL–PEG–PCL copolymeric-based micelles

, , &
Pages 1728-1739 | Received 06 Sep 2016, Accepted 30 Dec 2016, Published online: 01 Feb 2017

References

  • Allen TM, Cullis PR. 2004. Drug delivery systems: entering the mainstream. Science. 303:1818–1822.
  • Al-Musawi S, Naderi-Manesh H, Mohammad Hassan Z, Yeganeh H, Nikzad S, Kheiri Manjili H. 2014. Construction of polyurethane polymeric-based nano-carriers for curcumin in cancer therapy. Modares J Med Sci Pathol. 17:25–39.
  • Bertl E, Bartsch H, Gerhäuser C. 2006. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther. 5:575–585.
  • Clarke JD, Dashwood RH, Ho E. 2008. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 269:291–304.
  • Conaway CC, Wang C-X, Pittman B, Yang Y-M, Schwartz JE, Tian D, et al. 2005. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res. 65:8548–8557.
  • Danafar H, Hamidi M. 2013. A rapid and sensitive LC–MS method for determination of ezetimibe concentration in human plasma: application to a bioequivalence study. Chromatographia. 76:1667–1675.
  • Danafar H, Hamidi M. 2015. Simple and sensitive high-performance liquid chromatography (HPLC) method with UV detection for mycophenolic acid assay in human plasma. Application to a bioequivalence study. Adv Pharm Bull. 5:563–568.
  • Danafar H, Manjili H, Najafi M. 2016. Study of copolymer composition on drug loading efficiency of enalapril in polymersomes and cytotoxicity of drug loaded nanoparticles. Drug Res. 66:495–504.
  • Danafar H, Rostamizadeh K, Davaran S, Hamidi M. 2016. Drug-conjugated PLA–PEG–PLA copolymers: a novel approach for controlled delivery of hydrophilic drugs by micelle formation. Pharm Dev Technol. [Epub ahead of print]. DOI: 10.3109/10837450.2015.1125920
  • Danafar H. 2016a. Applications of copolymeric nanoparticles in drug delivery systems. Drug Res. 66:506–519.
  • Danafar H. 2016b. Study of the composition of polycaprolactone/poly (Ethylene Glycol)/polycaprolactone copolymer and drug-to-polymer ratio on drug loading efficiency of curcumin to nanoparticles. Jundishapur J Nat Pharm Prod. [Epub ahead of print]. DOI: 10.17795/jjnpp-34179
  • Do D, Pai S, Rizvi SA, D'Souza MJ. 2010. Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy. Int J Pharm. 386:114–121.
  • Enriquez GG, Rizvi S, D'Souza MJ, Do DP. 2013. Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy. Int J Nanomedicine. 8:1393–1402.
  • Facchini A, Stanic I, Cetrullo S, Borzì RM, Filardo G, Flamigni F. 2011. Sulforaphane protects human chondrocytes against cell death induced by various stimuli. J Cell Physiol. 226:1771–1779.
  • Foltz CJ, Ullman-Cullere M. Guidelines for assessing the health and condition of mice. RESOURCE. 1999;28.
  • Gasper AV, Al-janobi A, Smith JA, Bacon JR, Fortun P, Atherton C, et al. 2005. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr. 82:1283–1291.
  • Gupta SC, Kim JH, Prasad S, Aggarwal BB. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434.
  • Hanlon N, Coldham N, Gielbert A, Kuhnert N, Sauer MJ, King LJ, Ioannides C. 2008. Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br J Nutr. 99:559–564.
  • Holst B, Williamson G. 2004. A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep. 21:425–447.
  • Izadi A, Manjili HK, Ma’mani L, Moslemi E, Mashhadikhan M. 2015. Sulforaphane loaded PEGylated iron oxide-gold core shell nanoparticles: a promising delivery system for cancer therapy. Am Int J Contemp Sci Res. 2:84–94.
  • Izadi A, Moslemi E, Poorhosseini SM, Yassaee VR, Kheiri HR, Elikai HR. UBD identify in paraffin tissues in patients with colorectal cancer. 2014.
  • Kumari A, Yadav SK, Yadav SC. 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B. 75:1–18.
  • Ma'mani L, Nikzad S, Kheiri-Manjili H, al-Musawi S, Saeedi M, Askarlou S, Foroumadi A, Shafiee A. 2014. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy. Eur J Med Chem. 83:646–654.
  • Manjili HK, Ghasemi P, Malvandi H, Mousavi MS, Attari E, Danafar H. 2016. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. Eur J Pharm Biopharm. [Epub ahead of print]. DOI: 10.1016/j.ejpb.2016.10.003
  • Manjili HK, Malvandi H, Mousavi MS, Danafar H. 2016. Preparation and physicochemical characterization of biodegradable mPEG-PCL core-shell micelles for delivery of artemisinin. Pharm Sci. 22:234–243.
  • Manjili HK, Naderi-Manesh H, Mashhadikhan M, Ma'mani L, Nikzad S. 2014. The effect of iron-gold core shell magnetic nanoparticles on the sensitization of breast cancer cells to irradiation. J Paramed Sci. 5:85–90.
  • Manjili HK, Sharafi A, Danafar H, Hosseini M, Ramazani A, Ghasemi MH. 2016. Poly (caprolactone)–poly (ethylene glycol)–poly (caprolactone) (PCL–PEG–PCL) nanoparticles: a valuable and efficient system for in vitro and in vivo delivery of curcumin. RSC Adv. 6:14403–14415.
  • Nie S. 2010. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond). 5:523–528.
  • Saleem K, Wani WA, Haque A, Lone MN, Hsieh M-F, Jairajpuri MA, Ali I. 2013. Synthesis, DNA binding, hemolysis assays and anticancer studies of copper (II), nickel (II) and iron (III) complexes of a pyrazoline-based ligand. Future Med Chem. 5:135–146.
  • Danafar H, Sharafi A, Kheiri Manjili H, Andalib S. 2016. Sulforaphane delivery using mPEG–PCL co-polymer nanoparticles to breast cancer cells. Pharm Dev Technol. [Epub ahead of print]. DOI: 10.3109/10837450.2016.1146296
  • Sharma P, Kapoor S. 2015. Biopharmaceutical aspects of Brassica vegetables. J Pharmacogn Phytochem. 4:140–147.
  • Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 70:1–20.
  • Sutaria D, Grandhi BK, Thakkar A, Wang J, Prabhu S. 2012. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int J Oncol. 41:2260–2268.
  • Wang F, Bronich TK, Kabanov AV, Rauh RD, Roovers J. 2005. Synthesis and evaluation of a star amphiphilic block copolymer from poly (ɛ-caprolactone) and poly (ethylene glycol) as a potential drug delivery carrier. Bioconjugate Chem. 16:397–405.
  • Zhang Y, Tang L, Gonzalez V. 2003. Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther. 2:1045–1052.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.